US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

239.49

+3.101.31%

Post-market: 239.10-0.3953-0.17%16:23 EDT

Volume:28.69K

Turnover:6.84M

Market Cap:475.75M

PE:- -

High:239.49

Open:236.45

Low:236.45

Close:236.40

52wk High:244.35

52wk Low:160.91

Shares:1.99M

Float Shares:1.99M

Volume Ratio:3.93

T/O Rate:1.44%

Dividend:0.95

Dividend Rate:0.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?

Simply Wall St.

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Political and General News Events from August 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Revolution Medicines, Inc. : Needham Raises Target Price to $275 from $240

THOMSON REUTERS

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

Revolution Medicines Set to Post 'Strong Launch' for Rasonque, UBS Says

MT Newswires Live

Political and General News Events from August 28

US Regulator Approves Novel Pancreatic Cancer Therapy, Marking Major Win for Independent Biotech

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BBH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":239.4918,"timestamp":1788292800000,"preClose":236.396,"halted":0,"volume":28687,"hourTrading":{"tag":"盘后","latestPrice":239.0965,"preClose":239.4918,"latestTime":"16:23 EDT","volume":18,"amount":4311.9544,"timestamp":1788294232639,"change":-0.3953,"changeRate":-0.001651,"amplitude":0},"delay":0,"changeRate":0.013095822264336223,"floatShares":1986503,"shares":1986503,"eps":0,"marketStatus":"Not Yet Opened","change":3.0958,"latestTime":"09-01 16:00:00 EDT","open":236.45,"high":239.4918,"low":236.45,"amount":6840002,"amplitude":0.012867,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":236.396,"sharesOutstanding":1976503,"nav":236.27832,"aum":469367592.63,"dividendRate":0.00395,"bidAskSpread":0.001117,"postHourTrading":{"tag":"盘后","latestPrice":239.0965,"preClose":239.4918,"latestTime":"16:23 EDT","volume":18,"amount":4311.9544,"timestamp":1788294232639,"change":-0.3953,"changeRate":-0.001651,"amplitude":0},"volumeRatio":3.928327,"impliedVol":0.1997,"impliedVolPercentile":0.6056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":1986503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.928327,"shares":1986503,"dividePrice":0.9459,"high":239.4918,"amplitude":0.012867,"preClose":236.396,"low":236.45,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":239.4918,"eps":0,"divideRate":0.00395,"volume":28687,"delay":0,"ttmEps":0,"open":236.45,"prevYearClose":189.2649,"prevWeekClose":236.4764,"prevMonthClose":236.396,"prevQuarterClose":203.2373,"fiveDayClose":243.7264,"twentyDayClose":208.0336,"sixtyDayClose":187.9971},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664854881","title":"Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854881","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854881?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:17","pubTimestamp":1788218267,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals has secured past FDA approval for Pasatru (garetosmab-grts), a VelocImmune-derived monoclonal antibody that reduces new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, based on Phase 3 OPTIMA trial data.\nThis approval introduces a new rare disease therapy that can be infused monthly, including in home settings, and is supported by strong lesion-reduction outcomes against placebo while carrying...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","LU0053666078.USD","LU0114720955.EUR","LU1917777945.USD","LU2089984988.USD","LU2362540622.SGD","LU2106854487.HKD","LU0058720904.USD","LU0109394709.USD","ARTY","LU0320765992.SGD","BK4585","AIPO","LU0882574055.USD","TBXU","LU1974910355.USD","VTHR","LU0823416689.USD","LU0823434583.USD","LU2237438978.USD","LU2468319806.SGD","REGN","LU2362541513.USD","LU0823434740.USD","LU0289739699.SGD","LU0889565916.HKD","LU2023250504.SGD","BK4195","CHAT","LU2362541273.HKD","HBCP","IBBQ","IBB","AGIX","BK4211","BBH","BK4139","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","LU1983299246.USD","LU1057294990.SGD","BK0046","BK4550","300485","IE00BLSP4239.USD","LU2112291526.USD","SG9999002224.SGD","CSL.AU","BK4505","BK4534","LU0109394709.USD","IE00B3T34201.USD","BIB","LU1883839398.USD","LU0868494617.USD","LU1894683348.USD","IE00BLSP4452.SGD","BK0028","BBIO","IBBQ","BK4566","LU0320765992.SGD","688235","TBXU","BBH","PFE","LU2242646821.SGD","IE00BJT1NW94.SGD","BK4007","OZEM","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","PJP","AMGN","IE0002270589.USD","LU0225284248.USD","LU0889565916.HKD","IE0002141913.USD","LU0306806265.USD","SGXZ57979304.SGD","PBE","IBB","LU0321505439.SGD","BK7511","SG9999001176.SGD","LU2468319806.SGD","IONS","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005748","title":"Political and General News Events from August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005748?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182117,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 31Aug 31 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2242646821.SGD","IE00B4R5TH58.HKD","LU2112291526.USD","IBB","BK4585","LU1571399168.USD","PBE","LU1061106388.HKD","BK4581","BK4566","LU0109394709.USD","IBBQ","LU2242652126.USD","BK4588","IE00BJT1NW94.SGD","LU0058720904.USD","LU0868494617.USD","IE0002141913.USD","BK4139","AMGN","LU1023059063.AUD","LU1983299246.USD","LU2468319806.SGD","BK4534","IE0009355771.USD","BK4599","LU2089984988.USD","PJP","IE00B2B36J28.USD","BBH","IE00BFTCPJ56.SGD","LU0122379950.USD","SG9999001440.SGD","BK4533","TBXU","LU1057294990.SGD","LU0889565916.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0289739699.SGD","IBB","LU2468319806.SGD","BK4599","LU2089984988.USD","LU2242646821.SGD","LU0320765992.SGD","BK4581","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4566","PJP","LU0058720904.USD","BK4534","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0868494617.USD","LU2112291526.USD","IE00BJT1NW94.SGD","IE0002141913.USD","BIB","IBBQ","LU1983299246.USD","AMGN","LU2242652126.USD","LU1571399168.USD","SG9999001440.SGD","LU1023059063.AUD","TBXU","IE0009355771.USD","LU0122379950.USD","LU1061106388.HKD","PBE","LU0889565916.HKD","LU0109394709.USD","BK4139","BK4585","BBH","BK4533","IE00BFTCPJ56.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079265","title":"Revolution Medicines, Inc. : Needham Raises Target Price to $275 from $240","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663079265?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:45","pubTimestamp":1788169510,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S00C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDNA","IE0009354923.USD","CANC","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0109394709.USD","IE00B4R5TH58.HKD","RVMD","LU0320765992.SGD","BK4139","IE0009355771.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","BBH","IE00BFTCPJ56.SGD","PTH","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","PBE","IBBQ","LU2089984988.USD","IBB","LU0058720904.USD","IE00B4R5TH58.HKD","BK4585","LU0289739699.SGD","LU1057294990.SGD","BK4566","LU0868494617.USD","PJP","LU1571399168.USD","AMGN","BK4139","LU2242646821.SGD","LU0889565916.HKD","IE0009355771.USD","BK4581","BBH","LU2468319806.SGD","TBXU","IE00BFTCPJ56.SGD","LU1983299246.USD","BK4533","IE00B2B36J28.USD","BK4534","LU0320765992.SGD","LU1061106388.HKD","LU2112291526.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4588","LU0122379950.USD","BK4599","IE00BJT1NW94.SGD","BIB","SG9999001440.SGD","LU1023059063.AUD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663202044","title":"Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2663202044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663202044?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:18","pubTimestamp":1788160736,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA6XK0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","IBBQ","BBH","PBE","IE0009355771.USD","LU1023059063.AUD","LU1983299246.USD","LU0058720904.USD","BK4139","LU2089984988.USD","LU0289739699.SGD","BK4533","LU1057294990.SGD","LU0868494617.USD","SG9999001440.SGD","LU0122379950.USD","AMGN","IBB","IE0002141913.USD","LU2112291526.USD","IE00BJJMRZ35.SGD","BK4581","BIB","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4588","PJP","LU0320765992.SGD","TBXU","BK4585","BK4599","LU1571399168.USD","IE00BJT1NW94.SGD","LU0109394709.USD","LU2242646821.SGD","LU0889565916.HKD","LU2468319806.SGD","LU2242652126.USD","LU1061106388.HKD","BK4534","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1571399168.USD","BMED","GILD","BK4583","LU1934455277.USD","LU0058720904.USD","BK4550","LU1934455863.HKD","LU1430594728.SGD","BK4578","BK4566","LU0114720955.EUR","LU1839511570.USD","LU0965508806.USD","LU0234570918.USD","LU2089984988.USD","BBH","LU1934455194.USD","LU0965509010.AUD","BK4532","LU1585245621.USD","LU1066051498.USD","IE00B3T34201.USD","MEDI","LU0122379950.USD","LU1066053197.SGD","IBBQ","BK4568","LU2468319806.SGD","LU2112291526.USD","BK4139","IBB","LU1023059063.AUD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU0823416689.USD","SG9999015945.SGD","BK4585","LU2324357040.USD","BK4588","LU0882574055.USD","LU0965509283.SGD","TMED","IE00B19Z3B42.SGD","LU0109394709.USD","BIB","IE00BKVL7J92.USD","LU0289739699.SGD","SG9999015978.USD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663464017","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663464017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663464017?lang=en_us&edition=fundamental","pubTime":"2026-08-29 22:30","pubTimestamp":1788013830,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Spyre Therapeutics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0128526141.USD","LFSC","XLV","BBH","LU0029874061.USD","PTH","LU0320765992.SGD","XBI","IE0009354923.USD","IE00BFTCPJ56.SGD","LABU","IE00BJT1NW94.SGD","BK4588","BK4585","IE00BJJMRZ35.SGD","IE0009355771.USD","IDNA","BK4139","IE00B4R5TH58.HKD","BK4581","HCSG","LU0889565916.HKD","IE0002141913.USD","IE00B2B36J28.USD","RVMD","LU0109394709.USD","SYRE","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019778","title":"Pharma Industry Stares Down Biggest Patent Cliff in Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019778","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019778?lang=en_us&edition=fundamental","pubTime":"2026-08-29 09:00","pubTimestamp":1787965200,"startTime":"0","endTime":"0","summary":"Most companies sell a hit product for as long as customers want it. For drugmakers, a clock starts before a drug is even approved: Patents run out, lower-priced copycats flood in and sales collapse. B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","VHT","LU1883839398.USD","LU0320765489.SGD","IHE","LU0320765646.SGD","LU0980610538.SGD","GLAM","LU1037948541.HKD","LU0267386448.USD","LU1989772923.USD","LU0683600562.USD","LU2357305700.SGD","LU0203345920.USD","SG9999015952.SGD","LU1548497426.USD","LU1162221912.USD","LU0477156953.USD","LU2491050154.USD","IE00BGHQF631.EUR","RXL","LU1720051017.SGD","RVMD","SG9999014559.SGD","LU1244550494.USD","BK4548","LU0154236417.USD","LU0323591593.USD","LU1979441026.SGD","LU0471298777.SGD","LU1496350171.SGD","LU2111349929.HKD","LU0237698245.USD","LU0256863902.USD","IE00B19Z3581.USD","GDOC","LU0859254822.USD","LU0306806265.USD","BK4566","IE00BFSS8Q28.SGD","LU0823434583.USD","BK4533","LU1032466523.USD","BK4599","LU2456880835.USD","BK4559","LU0057025933.USD","LU1839511570.USD","LU0289961442.SGD","LU1670711040.USD","BBH","IE00BKDWB100.SGD","LU0097036916.USD","NVOX","LU1989771016.USD","IE00B4JS1V06.HKD","LU0354030511.USD","LU2125154935.USD","LU0820562030.AUD","LU0889565916.HKD","GNOM","MEDI","LU0472753341.HKD","LU1267930490.SGD","LU1236620750.USD","SGXZ81514606.USD","LU0471298694.HKD","IE00B1BXHZ80.USD","LU0942090050.USD","SGXZ31699556.SGD","LU2125909247.SGD","LU0289739343.SGD","BK4532","LU1732800096.USD","IE00BBT3K403.USD","LU0208291251.USD","LU2125909593.SGD","WDNA","NVOH","SGXZ51526630.SGD","IE00BSNM7G36.USD","LU1929549753.HKD","IE00BFSS7M15.SGD","SG9999001176.USD","IE00BLSP4452.SGD","LU0545039389.USD","IYH","BK4139","LU0211328371.USD","LU2023250843.SGD","MRK","LU0006306889.USD","SG9999015358.SGD","IE00BWXC8680.SGD","IE000BZT7R73.USD","LU2028103732.USD","LU2756315664.SGD","LU1145028129.USD","LU0949170772.SGD","IE00BKPKM429.USD","LU2237443465.HKD","LU0320765992.SGD","LU2602419157.SGD","LU1868837136.USD","LU1074936037.SGD","SG9999002224.SGD","LU2213496289.HKD","BK4588","LU2552382132.HKD","LU0786609619.USD","LU1066051225.USD","MRNX","LU0985320562.USD","LU0238689110.USD","LU1066051498.USD","LU1093756325.SGD","PJP","LU1868836591.USD","CURE","LU0823416689.USD","LU0640476718.USD","IE0002270589.USD","LU0130517989.USD","LU0868494617.USD","LU1923622614.USD","LU0289739699.SGD","IXJ","LU0321505868.SGD","LU2023250504.SGD","IE00B4R5TH58.HKD","LU1037948897.HKD","BK4581","LU1366192091.USD","LU0882574055.USD","LU1035773651.USD","LU0708994859.HKD","LU1814569148.SGD","LU2133065610.SGD","LU0203202063.USD","LU0795875169.SGD","LU0820561818.USD","LU2361044949.HKD","LU1551013342.USD","LU2236285917.USD","LU2896262040.SGD","HRTS","FHLC","LU0395794307.EUR","LGHT","LU2112291526.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IE000SO60NU8.SGD","LU0096364046.USD","IE0000B7K699.USD","LU1868837300.USD","LU2129689431.USD","LU0787776722.HKD","AGNG","LU0316494557.USD","IE00BFTCPJ56.SGD","BMED","LU2242646821.SGD","LU0321505439.SGD","LU2089984988.USD","LU0069063385.USD","LU2023250330.USD","LU0225771236.USD","IE00B3PB1722.GBP","LU0310800379.SGD","LU1941712264.USD","SG9999014575.USD","LU0354030438.USD","LU0965509101.SGD","MRNA","LU0158827948.USD","IE00BJJMRZ35.SGD","LU2271345857.HKD","SG9999014542.SGD","LU1712237335.SGD","LU2552382058.USD","LLYZ","LU1934455277.USD","LU1291159041.SGD","LU2471134952.CNY","LU0553294199.USD","IE00BVYPNV92.GBP","LU0965509010.AUD","LU0708995401.HKD","LU2347655156.SGD","SG9999017495.SGD","LU0122379950.USD","LU1989772840.SGD","LU2746668461.USD","LU1988902786.USD","LU1244550221.USD","LU0058720904.USD","LU1551013425.SGD","LU2168564149.EUR","FTXH","BK4550","LU2417539215.USD","LU2168564222.USD","LU0965508806.USD","LU2242652126.USD","SG9999014914.USD","LU2237443382.USD","LU0964807845.USD","LU2237443895.HKD","LU0256863811.USD","LU1430594728.SGD","LU0079474960.USD","LU1267930573.SGD","LU0320765059.SGD","LU0306807586.USD","LU2750360641.GBP","SG9999001176.SGD","LU0738911758.USD","LU1236620834.HKD","JDOC","IE00B775H168.HKD","LU0210536198.USD","LU1069347547.HKD","LU1934455194.USD","TRUH","ILDR","SGXZ57979304.SGD","LU0689472784.USD","LU0795875086.SGD","LU0266013472.USD","LU2756315318.SGD","LU1629891620.HKD","ELIL","LU0234570918.USD","LU2360032135.SGD","BK4501","LU2462157665.USD","LU0211327993.USD","SGXZ99366536.SGD","LU2468319806.SGD","BK4585","PPH","LU1670628061.USD","LU1670711123.USD","LU1116320901.HKD","LU1066053197.SGD","BK4534","LU2063271972.USD","LU0170899867.USD","BK4007","LU1934455863.HKD","LU2264538146.SGD","IE00BK4W5L77.USD","LU2211815571.USD","LU0861579265.USD","IE00BJJMRX11.SGD","LU1804176565.USD","CANC","LU2746668974.SGD","SG9999011175.SGD","LU1201861249.SGD","LU1280957306.USD","LU0070302665.USD","MEDX","LU1868836757.USD","MRNY","LU0353189680.USD","LU1035775433.USD","LU1670710588.SGD","LU2491049909.HKD","LU2237443622.USD","IE0009354923.USD","LU0098860793.USD","IE000MB6IJN5.SGD","LU0114720955.EUR","LLYX","LU0385154629.USD","IE00BN29S564.USD","LU0029864427.USD","LU2089284900.SGD","LU2596442595.SGD","LU0211331839.USD","IDNA","LU2087625088.SGD","LU2750360997.AUD","LU0466842654.USD","SG9999001440.SGD","LU1623119135.USD","LU0985481810.HKD","LU1699723380.USD","LU2108987350.USD","LU2471134523.USD","LU0198837287.USD","XLV","IE00BN8TJ469.HKD","LU0820561909.HKD","LU2361045086.USD","LU1496350502.SGD","LU1720051108.HKD","LU2265009873.SGD","SG9999003800.SGD","LU0726765562.USD","THNR","LU0882574139.USD","LU2433249047.HKD","LU0130102774.USD","IE0005OL40V9.USD","LU2237438978.USD","LU0511384066.AUD","BK4551","PAWZ","LU1917777945.USD","LLII","LU1974910355.USD","LU0265550359.USD","LU1323610961.USD","LU2360106947.USD","LU1670710661.SGD","NVOC","IE00BJJMRY28.SGD","LU0648001328.SGD","IE00BLSP4239.USD","LU1066051811.HKD","LU1232071149.USD","IE000M9KFDE8.USD","PTH","LU2129689514.USD","LU2552382215.SGD","LU0061475181.USD","LU0174119429.USD","ELIS","IE00B1XK9C88.USD","ABBV","IE00BFXG1179.USD","SG9999018865.SGD","LU0203347892.USD","SG9999014898.SGD","LU2471134796.USD","LU2089283258.USD","IE0001KFT4U8.USD","IE00BDGV0183.EUR","LU0456855351.SGD","LU2324357040.USD","SG9999002232.USD","LU2347655073.USD","LU0689626769.HKD","LU1116320737.USD","LU1941712348.USD","LU2023251221.USD","LU0417517546.SGD","LU2168563687.JPY","LU2361044865.SGD","LU0345770993.USD","LU1244550577.SGD","LU1670627923.USD","LU2237443978.SGD","IE00BJLML261.HKD","LU1868836914.USD","LU0345770308.USD","LU0124676726.USD","BK4568","LU2462591350.SGD","LU0158827781.USD","BMY","SG9999015341.SGD","LU2129689605.HKD","IE0004445239.USD","SG9999015978.USD","IE00B2B36J28.USD","LU2106854487.HKD","LU1571399168.USD","SG9999018857.SGD","LU1718418525.SGD","MHIP","LU0203201768.USD","LU0106261372.USD","LU2471134879.HKD","LU0912757837.SGD","SG9999014906.USD","LU1069344957.HKD","LU2168564495.EUR","LU2087621335.USD","LU0234572021.USD","IE00BZ1G4Q59.USD","LU0109394709.USD","NVO","LU0432979614.USD","LU2168564065.EUR","BK4516","LU0109391861.USD","IE00BKVL7J92.USD","IE00B42XCP33.USD","TMED","OZEM","LLY","LU1003077747.HKD","LU0133085943.USD","LU0868494708.USD","LU0128525929.USD","LU0225284248.USD","IE000WAW04H5.SGD","LU0353189763.USD","LU2125154778.USD","IE000F7OJYX1.SGD","LU0310799852.SGD","LU1061106388.HKD","LU2237443549.SGD","LU1261432733.SGD","LU1023059063.AUD","LU1983299246.USD","GB00BDT5M118.USD","SG9999014880.SGD","LU0225283273.USD","LU1691799644.USD","IE00BK4W5M84.HKD","LU0661504455.SGD","IE00BVYPNW00.USD","LU1585245621.USD","IE00B19Z3B42.SGD","LU1732799900.SGD","SG9999013999.USD","LU0943347566.SGD","SG9999015945.SGD","LU1093756168.USD","IE00B7KXQ091.USD","LU0672654240.SGD","SG9999014567.USD","LU0965509283.SGD","LU2461242641.AUD","LU0094547139.USD","LU1064131342.USD","LU1127390331.HKD","LU0265550946.USD","LU1057294990.SGD","IE0009355771.USD","LU2491050071.SGD","LU0823434740.USD","LU1267930730.SGD","LU2357627491.SGD","IE0004445015.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015099","title":"Crinetics Shareholders Approve Vertex Acquisition at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015099","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015099?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:33","pubTimestamp":1787952818,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals ( ($CRNX) ) has provided an update. On August 28, 2026, Crinetics Pharmaceuticals shareholders held a special meeting at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999001176.SGD","LU2468319806.SGD","BK4532","IBBQ","BIB","LU2417539215.USD","IE0009355771.USD","IE0002141913.USD","LU1674673691.USD","BBH","LU1778281490.HKD","IE00B894F039.SGD","LU0061475181.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","BK4585","BK4567","LU0079474960.USD","LU1069344957.HKD","LU2462157665.USD","IDNA","LU0432979614.USD","LU2236285917.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","TBXU","LU0256863811.USD","LU1815336091.USD","LU2362540622.SGD","LU1093756168.USD","LU1674673428.USD","BK4023","LU0289739699.SGD","IE00BZ9MQY76.HKD","IE00B19Z9P08.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","GNMX","LU0823416689.USD","BK4588","LU0234570918.USD","PBE","LU0757428866.USD","IBB","VERX","BK4533","IE00BJT1NW94.SGD","VRTX","IE00B19Z3581.USD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701587","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701587?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:35","pubTimestamp":1787949300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.14% to $145.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.Gilead Sciences Inc. closed 7.38% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and Abbott Laboratories  rose 0.79% to $112.47.Trading volume  remained 3.2 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0861579265.USD","IBB","LU1839511570.USD","SG9999015952.SGD","SG9999015978.USD","LU1061106388.HKD","LU0320765992.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","LU1571399168.USD","SG9999015986.USD","IE00B19Z3581.USD","IE0002270589.USD","LU0289739699.SGD","LU0965509101.SGD","BK4588","LU2112291526.USD","IE00BSNM7G36.USD","LU1037948897.HKD","LU1066053197.SGD","LU2357627491.SGD","BBH","MEDI","IE00B3T34201.USD","IBBQ","LU0109394709.USD","LU0965508806.USD","LU1934455277.USD","LU2087621335.USD","LU0058720904.USD","LU0965509010.AUD","BK4532","LU0882574055.USD","BK4566","LU1430594728.SGD","LU1037948541.HKD","IE00B7SZLL34.SGD","SG9999015945.SGD","GILD","BMED","LU1057294990.SGD","LU1585245621.USD","LU2468319806.SGD","LU0122379950.USD","LU0234570918.USD","LU0859254822.USD","BK4583","LU0889565916.HKD","LU1778281490.HKD","LU2324357040.USD","LU0823416689.USD","BK4585","BK4139","BK4578","IE00BZ1G4Q59.USD","LU1023059063.AUD","BK4568","IE00BKVL7J92.USD","LU1674673691.USD","LU0114720955.EUR","LU1934455863.HKD","LU2089984988.USD","TMED","LU1674673428.USD","TBXU","LU0965509283.SGD","BIB","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015807","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015807?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:34","pubTimestamp":1787949240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.05% to $432.42 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.This was the stock's fourth consecutive day of losses.Amgen Inc. closed 3.27% below its 52-week high of $447.03, which the company reached on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and AbbVie Inc.  fell 1.03% to $255.48.Trading volume  remained 889,592 below its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU0109394709.USD","LU1061106388.HKD","LU0889565916.HKD","LU1571399168.USD","BK4581","LU0320765992.SGD","LU2112291526.USD","IE00B2B36J28.USD","BK4534","IE00BJT1NW94.SGD","IBB","LU0122379950.USD","BK4533","PJP","LU0058720904.USD","LU2089984988.USD","BK4566","BBH","LU0868494617.USD","LU1023059063.AUD","TBXU","SG9999001440.SGD","IE0002141913.USD","LU1983299246.USD","BIB","BK4588","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","PBE","LU1057294990.SGD","IBBQ","LU2242652126.USD","04332","LU0289739699.SGD","IE0009355771.USD","BK4599","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018885","title":"Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018885","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018885?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:20","pubTimestamp":1787937637,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock was down roughly 2% on Friday alongside an FDA update concerning HIV drug Bixlenvo.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GILD","BK4578","LU1571399168.USD","LU1934455863.HKD","IE00BKVL7J92.USD","LU1778281490.HKD","BIB","BK4566","IE00B3T34201.USD","LU1934455194.USD","IBB","BK4585","LU0965509101.SGD","LU1066051498.USD","LU2357627491.SGD","TBXU","BK4139","LU1934455277.USD","SG9999015978.USD","LU1057294990.SGD","LABU","BK4588","LU0823416689.USD","IE00B19Z3581.USD","IBBQ","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU0965509010.AUD","LU2112291526.USD","LU0859254822.USD","BBH","LU0882574055.USD","IE0002270589.USD","IE00B7SZLL34.SGD","LU0320765992.SGD","LU1037948897.HKD","BK4532","LU0109394709.USD","LU1674673691.USD","MEDI","TMED","LU0889565916.HKD","BMED","LU0114720955.EUR","LU1037948541.HKD","SG9999015986.USD","LU1066053197.SGD","SG9999015945.SGD","LU1585245621.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097210","title":"Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097210","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663097210?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934634,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. Vertex’s new Phase 1 study, officially titled “A Phase 1, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRTX","LU1815336091.USD","IBBQ","BK4211","SG9999013999.USD","LU0889565916.HKD","LU0417517546.SGD","IE0009355771.USD","LU1585245621.USD","IE00B19Z3581.USD","LU2417539215.USD","LU1559883803.SGD","BK4585","BK4588","LU0823416689.USD","LU2362540622.SGD","BIB","IE0002270589.USD","TBXU","SGXZ57979304.SGD","LU2362541273.HKD","SG9999001176.USD","LU2362541513.USD","BK4139","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","BK4023","LU1674673428.USD","IE00B894F039.SGD","IE00BZ9MQY76.HKD","LU2089984988.USD","LU0566484027.USD","LU2324357040.USD","ISBC","LU2468319806.SGD","VERX","LU0320765992.SGD","BBH","IBB","IE00B2B36J28.USD","LU1093756325.SGD","PBE","BK4567","GNMX","IDNA","LU2237438978.USD","LU0058720904.USD","SG9999001176.SGD","LU1430594728.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663225097","title":"Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663225097","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663225097?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934627,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s latest psoriasis study update spotlights apremilast (AMG 407) for ki...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242652126.USD","LU2242646821.SGD","BBH","PBE","BIB","LU2468319806.SGD","AMGN","IE0009355771.USD","BK4533","IBBQ","LU1023059063.AUD","LU1057294990.SGD","BK4599","BK4139","SG9999001440.SGD","TBXU","IE00BFTCPJ56.SGD","BK4581","BK4585","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0109394709.USD","IE0002141913.USD","LU1061106388.HKD","LU0058720904.USD","BK4211","LU0122379950.USD","BK4566","LU1571399168.USD","BK4534","LU0289739699.SGD","LU1983299246.USD","BK4588","IBB","LU0889565916.HKD","ISBC","LU0868494617.USD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU2112291526.USD","LU0320765992.SGD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663975310","title":"Revolution Medicines Set to Post 'Strong Launch' for Rasonque, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2663975310","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663975310?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:18","pubTimestamp":1787933923,"startTime":"0","endTime":"0","summary":"Revolution Medicines  should post \"strong launch numbers\" for pancreatic cancer drug Rasonque , which would serve as a key driver of its 2026 and 2027 revenue, UBS Securities said in a Thursday note.The US Food and Drug Administration approved Rasonque for the treatment of adult patients with metastatic pancreatic adenocarcinoma, with the company to price the therapy at $39,800 for a 30-day supply.Street consensus for the company's 2026 and 2027 revenue already increased following the approval, but the updated projections remain achievable, UBS said. Revolution Medicines already had 2,000 patients on its expanded access program as of Q2, the brokerage noted.The consensus is for $152 million revenue in 2026 and $1.10 billion in 2027, while UBS estimates $193 million in 2026 and $1.91 billion in 2027, according to the note.UBS also noted the upcoming phase 3 data on daraxonrasib in non-small cell lung cancer by year-end 2027 as Revolution Medicines' next major clinical catalyst.UBS raise","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","RVMD","IE0002141913.USD","CANC","LU0109394709.USD","PTH","BBH","BK4139","IDNA","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098405","title":"Political and General News Events from August 28","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098405?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:30","pubTimestamp":1787920229,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 28Aug 28 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P0YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU2468319806.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IBBQ","LU2242652126.USD","BK4585","IE00BJJMRZ35.SGD","PJP","TBXU","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0122379950.USD","IE0009355771.USD","BK4533","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0868494617.USD","LU0320765992.SGD","BK4588","IE0002141913.USD","BK4566","LU1571399168.USD","BK4599","LU1023059063.AUD","LU2242646821.SGD","PBE","LU1061106388.HKD","LU0289739699.SGD","BK4534","IBB","LU0889565916.HKD","SG9999001440.SGD","AMGN","BIB","LU1983299246.USD","BK4139","LU2089984988.USD","BBH","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145744656","title":"US Regulator Approves Novel Pancreatic Cancer Therapy, Marking Major Win for Independent Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=1145744656","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145744656?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:24","pubTimestamp":1787912643,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has officially approved Revolution Medicines' self-developed pancreatic cancer treatment, Rasonque, this week. This approval represents a significant triumph for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00BJT1NW94.SGD","LABU","LU0889565916.HKD","BBH","CANC","IE0009354923.USD","LU0320765992.SGD","PTH","IDNA","IE0002141913.USD","IE00BJJMRZ35.SGD","RVMD","BK4585","BK4139","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4588","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762030","title":"Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762030","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762030?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:17","pubTimestamp":1787883449,"startTime":"0","endTime":"0","summary":"Gilead breaks ground on Foster City biologics facility in $32 billion US investment pushGilead broke ground on its Chess biologics facility at its Foster City, California headquarters as part of a pla","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL98vB5b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948897.HKD","IE0002270589.USD","LU0859254822.USD","LU0965508806.USD","LU0965509101.SGD","BMED","GILD","IBB","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","LU1674673428.USD","LU1066053197.SGD","BIB","LU0234570918.USD","SG9999015952.SGD","LU1061106388.HKD","LU0109394709.USD","IE00B19Z3581.USD","BK4578","LU1430594728.SGD","LU1066051498.USD","LU1037948541.HKD","BK4568","LU0289739699.SGD","BBH","LU0861579265.USD","IBBQ","LU2357627491.SGD","LU2468319806.SGD","LU0058720904.USD","BK4532","LU0320765992.SGD","LU0823416689.USD","LU0965509283.SGD","IE00BSNM7G36.USD","LU2324357040.USD","LU1571399168.USD","LU0889565916.HKD","BK4583","TBXU","LU1934455194.USD","LU1674673691.USD","TMED","LU1057294990.SGD","LU2087621335.USD","MEDI","LU0965509010.AUD","LU2112291526.USD","LU1934455863.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}